Non-infectious Uveitis
22
1
3
11
Key Insights
Highlights
Success Rate
65% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 42/100
27.3%
6 terminated out of 22 trials
64.7%
-21.8% vs benchmark
27%
6 trials in Phase 3/4
73%
8 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (22)
Periodontal Status and Cytokine Levels in Patients With Non-Infectious Uveitis
Mindfulness Approach for Reducing Anxiety and Gloom in Ocular Inflammatory Diseases
Intravitreal Adalimumab Versus Subcutaneous Adalimumab in Non-infectious Uveitis
Incidence of Macular Edema in a Uveitis Population
A Safety Study of Intravitreal PP-001 in Patients With Chronic, Non-Infectious Uveitis
Prospective CoHoRt Of Non-infectious Intermediate, pOsterior or panuveitiS
Evaluation of EYS606 in Patients With Non-infectious Posterior, Intermediate or Panuveitis
A 48 Week Study to Evaluate the Efficacy and Safety of Two (2) EYS606 Treatment Regimens in Subjects With Active Chronic Non-infectious Uveitis (CNIU)
Study to Evaluate the Efficacy and Safety of Filgotinib in Adults With Active Noninfectious Uveitis
Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert
Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis
Utilization and Safety of the Mk II Inserter and the Safety of the FAI Insert in Non-Infectious Uveitis
Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS
Ozurdex® in Patients With Non-infectious Uveitis Affecting the Posterior Segment of the Eye
Safety and Efficacy of AIN457 in Noninfectious Uveitis
Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis
Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis
Efficacy and Safety of Voclosporin to Treat Active Noninfectious Uveitis
Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant
Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant vs Standardized Therapy